InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Perry Nicole D, Chief Executive Officer. Insider active across 2 companies, notably Apellis Pharmaceuticals, Inc.. In total, 6 reports have been recorded. Activity tracked since 30 April 2021. The latest transaction was disclosed on 2 August 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Perry Nicole D
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
1,000 shares@ US$3.7617.3% of flowCommon StockSEC:0001127602-21-022938:0
1,000 shares@ US$3.7617.4% of flowCommon StockSEC:0001127602-21-021194:0
1,000 shares@ US$3.2014.4% of flowCommon StockSEC:0001127602-21-019902:0
1,000 shares@ US$3.7616.8% of flowCommon StockSEC:0001127602-21-018704:0
1,000 shares@ US$3.7617.1% of flowCommon StockSEC:0001127602-21-015186:0
1,000 shares@ US$3.7617.0% of flowCommon StockSEC:0001127602-21-014986:0
6 of 6 declarations
About Perry Nicole D
Nicole D. Perry is the Chief Executive Officer and Vice President - Accounting at Apellis Pharmaceuticals, Inc. She is responsible for the strategic and operational leadership of the company. Her expertise in accounting and business management is essential to support the company's growth and performance.
